ENZON PHARMACEUT. Share · US2939041081 · 873997 (XNCM) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of ENZON PHARMACEUT.

No Price

30.04.2026 20:00

Current Prices from ENZON PHARMACEUT.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
UTC	ENZN	USD	30.04.2026 20:00	6,38 USD	-

Company Profile for ENZON PHARMACEUT. Share

Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

Company Data

Name ENZON PHARMACEUT.

Company Enzon Pharmaceuticals, Inc.

Website https://www.enzon.com

Primary Exchange

NASDAQ CAPITAL MARKET

WKN 873997

ISIN US2939041081

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Richard L. Feinstein CPA

Country United States of America

Currency EUR

Employees -

Address 20 Commerce Drive, 07016 Cranford

IPO Date 1984-02-15

Dividends from 'ENZON PHARMACEUT.'

Ex-Date	Dividend per Share
30.09.2019	0,12 USD
20.02.2019	0,06 USD
29.09.2017	0,15 USD
13.12.2016	0,15 USD
30.12.2015	0,25 USD
13.08.2015	0,50 USD
08.01.2015	0,10 USD
24.12.2013	0,45 USD
05.06.2013	1,60 USD
03.05.2013	1,60 USD